Literature DB >> 2820316

Expression of a Hodgkin and Reed-Sternberg cell associated antigen (Ki-1) in cutaneous lymphoid infiltrates.

E Ralfkiaer, J Bosq, K C Gatter, R Schwarting, J Gerdes, H Stein, D Y Mason.   

Abstract

Skin biopsy specimens from normal skin and from 115 patients with benign dermatoses, pre- or pseudo-malignant disorders or malignant cutaneous lymphomas have been examined immunohistologically for expression of the Reed-Sternberg cell associated antigen CD30 detected by monoclonal antibodies Ki-1 and Ber-H2. The antibodies stained the atypical cells in lymphomatoid papulosis, a proportion of the neoplastic cells in some cases of mycosis fungoides and most of the neoplastic cells in six large cell anaplastic/pleomorphic non-Hodgkin's lymphomas. The lymphoid cells in all other specimens were Ki-1- and Ber-H2-negative. In all cases, expression of the Ki-1/Ber-H2 antigen was accompanied by expression of activation and proliferation associated markers (i.e., HLA-DR, IL-2 receptor, transferrin receptor and the Ki-67 nuclear antigen). These data indicate the value of antibodies Ki-1 and Ber-H2 in distinguishing between lymphomatoid papulosis and other types of pre- or pseudo-malignant disorders and support the view that lymphomatoid papulosis, Hodgkin's disease and some types of non-Hodgkin's lymphoma constitute a spectrum of related disorders, originated from activated lymphoid cells.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 2820316     DOI: 10.1007/BF00431219

Source DB:  PubMed          Journal:  Arch Dermatol Res        ISSN: 0340-3696            Impact factor:   3.017


  28 in total

1.  High proliferative activity of Reed Sternberg associated antigen Ki-1 positive cells in normal lymphoid tissue.

Authors:  J Gerdes; R Schwarting; H Stein
Journal:  J Clin Pathol       Date:  1986-09       Impact factor: 3.411

2.  Atypical cells in lymphomatoid papulosis express the Hodgkin cell-associated antigen Ki-1.

Authors:  P Kaudewitz; H Stein; G Burg; D Y Mason; O Braun-Falco
Journal:  J Invest Dermatol       Date:  1986-04       Impact factor: 8.551

3.  T-cell growth factor receptor (Tac-antigen) expression in cutaneous lymphoid infiltrates.

Authors:  E Ralfkiaer; G L Wantzin; H Stein; K Thomsen; D Y Mason
Journal:  J Am Acad Dermatol       Date:  1986-10       Impact factor: 11.527

4.  A Hodgkin cell-specific antigen is expressed on a subset of auto- and alloactivated T (helper) lymphoblasts.

Authors:  R Andreesen; J Osterholz; G W Löhr; K J Bross
Journal:  Blood       Date:  1984-06       Impact factor: 22.113

5.  A monoclonal antibody that appears to recognize the receptor for human T-cell growth factor; partial characterization of the receptor.

Authors:  W J Leonard; J M Depper; T Uchiyama; K A Smith; T A Waldmann; W C Greene
Journal:  Nature       Date:  1982-11-18       Impact factor: 49.962

6.  Production of a monoclonal antibody specific for Hodgkin and Sternberg-Reed cells of Hodgkin's disease and a subset of normal lymphoid cells.

Authors:  U Schwab; H Stein; J Gerdes; H Lemke; H Kirchner; M Schaadt; V Diehl
Journal:  Nature       Date:  1982-09-02       Impact factor: 49.962

Review 7.  Immunohistological analysis of human lymphoma: correlation of histological and immunological categories.

Authors:  H Stein; K Lennert; A C Feller; D Y Mason
Journal:  Adv Cancer Res       Date:  1984       Impact factor: 6.242

8.  Immunopathology of cutaneous T-cell lymphomas.

Authors:  K Nasu; J Said; E Vonderheid; J Olerud; D Sako; M Kadin
Journal:  Am J Pathol       Date:  1985-06       Impact factor: 4.307

9.  Mycosis fungoides and Hodgkin's disease occurring in the same patient: report of three cases.

Authors:  W C Chan; M L Griem; P N Grozea; R J Freel; D Variakojis
Journal:  Cancer       Date:  1979-10       Impact factor: 6.860

10.  Inhibition of endogenous tissue alkaline phosphatase with the use of alkaline phosphatase conjugates in immunohistochemistry.

Authors:  B A Ponder; M M Wilkinson
Journal:  J Histochem Cytochem       Date:  1981-08       Impact factor: 2.479

View more
  7 in total

1.  Immunohistochemical distinction of lymphomatoid papulosis and pityriasis lichenoides et varioliformis acuta.

Authors:  F J Varga; E C Vonderheid; S M Olbricht; M E Kadin
Journal:  Am J Pathol       Date:  1990-04       Impact factor: 4.307

2.  Prognostic significance of CD30 (Ki-1/Ber-H2) expression in primary cutaneous large-cell lymphomas of T-cell origin. A clinicopathologic and immunohistochemical study in 20 patients.

Authors:  R C Beljaards; C J Meijer; E Scheffer; J Toonstra; W A van Vloten; S C van der Putte; M L Geerts; R Willemze
Journal:  Am J Pathol       Date:  1989-12       Impact factor: 4.307

3.  Primary and secondary cutaneous Ki-1+ (CD30+) anaplastic large cell lymphomas. Morphologic, immunohistologic, and clinical-characteristics.

Authors:  P Kaudewitz; H Stein; F Dallenbach; F Eckert; K Bieber; G Burg; O Braun-Falco
Journal:  Am J Pathol       Date:  1989-08       Impact factor: 4.307

Review 4.  CD30: from basic research to cancer therapy.

Authors:  Hiromi Muta; Eckhard R Podack
Journal:  Immunol Res       Date:  2013-12       Impact factor: 2.829

Review 5.  CD30 and CD30-Targeted Therapies in Hodgkin Lymphoma and Other B cell Lymphomas.

Authors:  Geetika Bhatt; Kami Maddocks; Beth Christian
Journal:  Curr Hematol Malig Rep       Date:  2016-12       Impact factor: 3.952

6.  Formalin-resistant leukocyte surface antigens in the diagnosis of cutaneous malignant lymphomas.

Authors:  A Hauschild; W Sterry
Journal:  Am J Pathol       Date:  1989-07       Impact factor: 4.307

7.  Cutaneous T cell lymphoma: immunocytochemical study on activation/proliferation and differentiation associated antigens in lymph nodes, skin, and peripheral blood.

Authors:  E Küng; K Meissner; T Löning
Journal:  Virchows Arch A Pathol Anat Histopathol       Date:  1988
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.